Skip to main content
Equibles

STATE STREET CORP

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 93751 BOSTON, MA
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$119,770
-$5,813 QoQ
Shares Held
122,215
-3.2% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 47 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. ATNM ranks #361 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in ATNM

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $119,770 122,215
2026-03-31 $125,583 126,215
2025-12-31 $171,652 126,215
2025-09-30 $201,944 126,215
2025-06-30 $310,821 222,015
2025-03-31 $1,038,796 645,215
2024-12-31 $782,554 621,075
2024-09-30 $1,132,980 602,649
2024-06-30 $4,511,580 609,673
2024-03-31 $4,313,116 550,845
2023-12-31 $2,574,757 506,842
2023-09-30 $3,096,112 522,992
2023-06-30 $3,574,236 481,703
2023-03-31 $907,341 96,015
2022-12-31 $940,554 88,315
2022-09-30 $555,086 75,215
2022-06-30 $361,784 75,215
2022-03-31 $322,006 63,015
2021-12-31 $336,511 55,992
2021-09-30 $489,887 55,292
2021-06-30 $437,359 55,292